Bottom Line:
Authors:
Background:
How the Study Was Conducted:
Results:
Discussion: "For the clinician, the atypical subtype deserves particular attention because this subtype is a strong predictor of adiposity. Accordingly, the screening of atypical features and, in particular, increased appetite in individuals with depression is crucial. The prescription of appetite-stimulating medication should be avoided in these patients and dietary measures during depressive episodes with atypical features are advocated. "
( JAMA Psychiatry . Published online June 4, 2014. doi:10.1001/jamapsychiatry.2014.411. Available pre-embargo to the media at http://media.jamanetwork.com .)
Editor's Note:
Some authors received two unrestricted grants from GlaxoSmithKline to build the cohort and complete the physical and psychiatric baseline investigations. Authors made funding disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Media Advisory:
To contact author Aurélie M. Lasserre, M.D., email aurelie.lasserre@chuv.ch
JAMA Psychiatry